Free Trial
OTCMKTS:SBMFF

Sino Biopharmaceutical (SBMFF) Stock Price, News & Analysis

Sino Biopharmaceutical logo
$0.47
0.00 (0.00%)
(As of 11/1/2024 ET)

About Sino Biopharmaceutical Stock (OTCMKTS:SBMFF)

Key Stats

Today's Range
$0.47
$0.47
50-Day Range
$0.38
$0.47
52-Week Range
$0.31
$0.49
Volume
N/A
Average Volume
300 shs
Market Capitalization
$8.89 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand. It also provides surgery/analgesia medicines, including flurbiprofen cataplasms under the brand Zepolas, limaprost tablets under the brand Kailitong, and recombinant human coagulation factor VIII for injection under the brand Anhengji; cardio-cerebral vascular medicines, such as irbesartan and hydrochlorothiazide tablets under the brand Yilunping and beraprost sodium tablets under the brand Kaina; and biosimilar medicines comprising adalimumab solution for injection under the brand Taibowei. In addition, the company develops oncology drugs, include benmelstobart, D-1553, TQ-B3139, and TQ-B3101; liver disease drugs, such as Lanifibranor and TQA2225/AP025; respiratory system drugs comprising TDI01, TQC2731, TCR1672, TQC3721, and TQH2722; and surgery/analgesia drugs, including PL-5, an antimicrobial peptide. Further, it is involved in the long-term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Receive SBMFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sino Biopharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

SBMFF Stock News Headlines

Sino Biopharmaceutical Sees Strong Q3 Financial Growth
Sino Biopharmaceutical to Boost Market Share through Strategic Acquisitions
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Sino Biopharmaceutical (SBMFF) Receives a Buy from Jefferies
Sino Biopharmaceutical Limited (SBMFF)
See More Headlines

SBMFF Stock Analysis - Frequently Asked Questions

Sino Biopharmaceutical's stock was trading at $0.4157 at the beginning of the year. Since then, SBMFF stock has increased by 13.8% and is now trading at $0.4730.
View the best growth stocks for 2024 here
.

Shares of SBMFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
11/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:SBMFF
Previous Symbol
NASDAQ:SBMFF
Employees
25,806
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Outstanding Shares
18,791,220,000
Free Float
N/A
Market Cap
$8.89 billion
Optionable
Not Optionable
Beta
0.59
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (OTCMKTS:SBMFF) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners